Etoricoxib
Etoricoxib is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase-2 (COX-2). It is used to treat acute and chronic pain, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and gout. Unlike traditional NSAIDs, etoricoxib selectively inhibits the COX-2 enzyme, which is responsible for the synthesis of pro-inflammatory prostaglandins. This selectivity minimizes gastrointestinal side effects associated with non-selective NSAIDs, which inhibit both COX-1 and COX-2 enzymes.
Pharmacology
Etoricoxib works by selectively inhibiting the enzyme cyclooxygenase-2 (COX-2). COX-2 is involved in the production of prostaglandins, which are substances that mediate inflammation and pain. By inhibiting COX-2, etoricoxib reduces the production of prostaglandins, thereby reducing inflammation and pain. Unlike traditional NSAIDs, etoricoxib does not significantly inhibit COX-1, an enzyme involved in the protection of the stomach lining, thus it has a lower risk of causing gastrointestinal side effects.
Indications
Etoricoxib is indicated for the treatment of:
Contraindications
Etoricoxib is contraindicated in patients with:
- Known hypersensitivity to etoricoxib or any of its components
- Active gastrointestinal bleeding or ulceration
- Severe heart failure
- Severe liver dysfunction
- Severe renal impairment
- Pregnancy and lactation
Side Effects
Common side effects of etoricoxib include:
Serious side effects may include:
- Cardiovascular events such as heart attack and stroke
- Gastrointestinal bleeding, ulceration, and perforation
- Severe skin reactions
- Liver and kidney impairment
Drug Interactions
Etoricoxib may interact with other medications, including:
- Warfarin and other anticoagulants
- Diuretics
- ACE inhibitors and angiotensin receptor blockers
- Lithium
- Methotrexate
Patients should inform their healthcare provider of all medications they are taking to avoid potential drug interactions.
Dosage and Administration
The dosage of etoricoxib varies depending on the condition being treated. It is available in tablet form and should be taken as prescribed by a healthcare provider. It is important not to exceed the recommended dose to avoid the risk of adverse effects.
Pharmacokinetics
Etoricoxib is well absorbed orally with peak plasma concentrations occurring approximately 1 hour after dosing. It has a plasma half-life of approximately 22 hours, allowing for once-daily dosing. Etoricoxib is metabolized in the liver and excreted primarily in the urine.
Regulatory Status
The availability and approval of etoricoxib vary by country. In some countries, it is available by prescription for the treatment of arthritis and pain. In others, its use may be limited or not approved due to concerns about cardiovascular and gastrointestinal risks.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
